In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice, CEO Albert Bourla told thousands of employees during a companywide town hall on May 2, according to a recording heard by CNBC. A day earlier,
Health, Fitness & Food
In this article GDRX Follow your favorite stocksCREATE FREE ACCOUNT Mike Mergen | Bloomberg | Getty Images The cost of prescription medications in the U.S. has increased 37% since 2014, far surpassing the rate of inflation, according to data from drug savings company GoodRx. Though the price increases have slowed this year in comparison to
In this article WBA Follow your favorite stocksCREATE FREE ACCOUNT In an aerial view, a customer enters a Walgreens store on January 04, 2024 in San Pablo, California. Justin Sullivan | Getty Images Shares of Walgreens plunged more than 14% on Thursday after the company reported fiscal third-quarter earnings that fell short of expectations and
In this article LLY NOVO.B-DK ZEAL-DK ALT VKTX GILD ORCL Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them
US President Joe Biden speaks during an event at the National Institutes of Health (NIH) in Bethesda, Maryland, US, on Thursday, Dec. 14 2023. Chris Kleponis | Bloomberg | Getty Images The Biden administration on Wednesday said it will impose inflation penalties on 64 prescription drugs for the third quarter of this year, lowering costs
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug
In this article GILD Follow your favorite stocksCREATE FREE ACCOUNT The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters Gilead‘s experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. None of the roughly 2,000 women in the
In this article MO Follow your favorite stocksCREATE FREE ACCOUNT NJOY Ace Source: NJOY The Food and Drug Administration on Friday authorized the first menthol-flavored electronic cigarettes for adult smokers, acknowledging that vaping flavors can reduce the harms of traditional tobacco smoking. The FDA said it authorized four menthol e-cigarettes from Njoy, the vaping brand recently
In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related
Neurotech startup Paradromics will be putting its brain implant on trial next year, as the race to be the leader in the nascent brain-computer interface space heats up. “The brain is a super fascinating organ. We have about 85 billion neurons and every neuron is a million times slower than a computer chip. And yet,
On Wall Street lately, it has seemingly been all artificial intelligence, all the time. That’s pushed tech heavyweights and Club names such as Apple , Nvidia , Microsoft and Broadcom higher and the S & P 500 to record highs along with them. That’s also left large swaths of the market in the dust. The
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. The injectable weight loss medication Wegovy at New City Halstead Pharmacy in Chicago on April 24, 2024. Scott Olson | Getty Images Good morning! More U.S. employers are covering a buzzy class of medications called GLP-1s for weight
In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. George Frey | Bloomberg | Getty Images Skyrocketing demand for a class of weight loss and diabetes treatments has
In this article MRK Follow your favorite stocksCREATE FREE ACCOUNT Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker
The Nasdaq Composite inched higher Friday to claim its fifth straight record close, as new data this past week showed a continued cooling of inflation and Treasury yields retreated. For the week: The tech-heavy Nasdaq gained 3.2%, while the S & P 500 rose 1.6% and the Dow Jones Industrial Average fell 0.5%. Economic updates
In this article Follow your favorite stocksCREATE FREE ACCOUNT Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment for their patients, rose by as much as 15% in its Nasdaq Stock Market trading debut on Friday, after going public under the ticker symbol “TEM.”
The S & P 500 and Nasdaq extended their record rallies this week following cooler-than-expected consumer inflation data Wednesday morning. While Fed rate cuts would likely benefit the overall stock market, several names in the CNBC Investing Club portfolio — from housing plays to autos to biotech — could really get a boost. Connecting the
New vaccine COMIRNATY® (COVID-19 Vaccine, mRNA) by Pfizer, available at CVS Pharmacy in Eagle Rock, CA. Irfan Khan | Los Angeles Times | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! It’s almost that time of the year again. A new
In this article ABT Follow your favorite stocksCREATE FREE ACCOUNT Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada. Ethan Miller | Getty Images Abbott Laboratories announced Monday it received approval from the U.S.
The weight loss boom is pushing consumers to spend more on protein supplement products, according to new data from The Vitamin Shoppe’s 2024 Health & Wellness Trend Report. The report is an annual study of 2,000 Americans that provides insight into top consumer trends in the nutritional supplements industry. As more Americans take weight loss
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 148
- Next Page »